你即將離開本站

並前往https://viracta.investorroom.com/2021-11-29-Viracta-Therapeutics-Announces-Orphan-Drug-Designation-Granted-by-FDA-for-its-All-Oral-Combination-of-Nanatinostat-and-Valganciclovir-Nana-val-for-the-Treatment-of-Epstein-Barr-Virus-Positive-Diffuse-Large-B-cell-Lymphoma

News Releases - Viracta | Investor Relations

Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir ...

確定！ 回上一頁

查詢 「drug@fda」的人也找了：

  1. fda查詢
    2.
  2. FDA logo
    3.
  3. FDA Approval 2021
    4.
  4. EMA drug search
    5.
  5. fda approved中文
    6.
  6. fda官網
    7.
  7. fda中文
    8.
  8. FDA Approved medical device
    9.